Skip to main content

Table 7 Baseline characteristics of open and VATS group after propensity score matching

From: Surgical outcomes of pulmonary metastasectomy in hepatocellular carcinoma patients according to approach method: thoracoscopic versus open approach

 

Total (n = 58)

Open (n = 29)

VATS (n = 29)

p value

Age (years)

54.0 ± 11.1

54.8 ± 9.3

53.2 ± 12.7

0.606

Sex (male)

51 (87.9%)

26 (89.7%)

25 (86.2%)

0.687

BCLC stage

   

0.284

 0

0

0

0

 A

13 (22.4%)

9 (31.0%)

4 (13.8%)

 B

21 (36.2%)

9 (31.0%)

12 (41.4%)

 C

24 (41.4%)

11 (38.0%)

13 (44.8%)

 D

0

0

0

ECOG performance status

   

0.339

 0

49 (84.5%)

24 (82.8%)

25 (86.2%)

 1

7 (12.1%)

3 (10.3%)

4 (13.8%)

 2

2 (3.4%)

2 (6.9%)

0

 3

0

0

0

 4

0

0

0

Etiology

   

0.362

 HBV

46 (79.3%)

24 (82.8%)

22 (75.9%)

 HCV

1 (1.7%)

0

1 (3.4%)

 Alcohol

2 (3.4%)

0

2 (6.9%)

 Unknown

9 (15.5%)

5 (17.2%)

4 (13.8%)

Child-Pugh classification

   

0.706

 A

50 (86.2%)

24 (82.8%)

26 (89.7%)

 B

8 (13.8%)

5 (17.2%)

3 (10.3%)

 C

0

0

0

Liver cirrhosis

19 (32.8%)

11 (37.9%)

8 (27.6%)

0.401

Treatment of HCC

   

0.730

 Surgery

48 (82.8%)

23 (89.3%)

25 (86.2%)

 TACE

10 (17.2%)

6 (20.7%)

4 (13.8%)

 RFA

0

0

0

  1. VATS video-assisted thoracic surgery, AFP alpha-fetoprotein, HBV hepatitis B virus, HCV hepatitis C virus, BCLC Barcelona Clinic Liver Cancer, PSM propensity score matching, ECOG Eastern Cooperative Oncology Group, TACE transarterial chemoembolization, RFA radiofrequency ablation